EUVIMEDEUVIMED entdecken
Multizentrische Studie

Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis

Maud Hulin, Victor Audigé, Adnan Baghli, Stéphane Larré, Pascal Eschwege, Karim Bensalah, Zine-Eddine Khene

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02578-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Maud Hulin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Reims University Hospital, Reims, France. maud.hulin@orange.fr. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Nephrectomy, Kidney Neoplasms, Margins of Excision. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The aim of the study was to determine the impact of positive surgical margins (PSM) after PN on very long-term recurrence in a contemporary cohort. METHODS: Patients who underwent PN for a localized renal tumour were included. Patients were stratified according to the presence of PSM. Data on patients' characteristics, the tumour, the peri- and postoperative events were collected. Disease-free survival (DFS) and overall survival (OS) were assessed by the Kaplan-Meier method and compared by the log-rank test. Sensitivity analyses using weighted propensity score analysis was performed to account for potential selection biases arising from the nonrandom allocation of patients to different groups. RESULTS: A total of 1115 patients were included in the study. The incidence of PSM was 5.4% (n = 61). The median follow-up time was 51 months for the PSM group and 61 months for the NSM group (p = 0.31). Recurrence rates were significantly higher in the PSM group (13%, n = 8) compared to the NSM group (7%, n = 73) (p = 0.05). This resulted in a significant reduction in DFS in the PSM group (p = 0.004), particularly pronounced in patients with clear cell renal cell carcinoma. Additionally, OS was significantly lower in the PSM group (p < 0.01). Propensity score analysis confirmed a decrease in DFS for the PSM group (p = 0.05), while there was no significant difference in OS between the two groups (p = 0.49). CONCLUSION: In this retrospective multicenter study, PSM impact on oncological outcomes, increasing recurrence, but no difference in OS was observed post-adjustment for biases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellNephrectomyKidney NeoplasmsMargins of ExcisionNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedAgedDisease-Free SurvivalRetrospective StudiesPropensity ScoreKaplan-Meier EstimateAdult

Stichwörter der Autor:innen

Kidney cancerPositive marginPrognosisRecurrenceRenal cell carcinoma

Autor:innen und Institutionen

  • Department of Urology, Reims University Hospital, Reims, France. maud.hulin@orange.fr.
  • Department of Urology, Reims University Hospital, Reims, France.
  • Department of Urology, Nancy University Hospital, Nancy, France.
  • Department of Urology, Rennes University Hospital, Rennes, France.

Zitieren

APA

Hulin, M., Audigé, V., Baghli, A., Larré, S., Eschwege, P., Bensalah, K., & Khene, Z. E. (2024). Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02578-0

Vancouver

Hulin M, Audigé V, Baghli A, Larré S, Eschwege P, Bensalah K, et al. Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02578-0

BibTeX
@article{Hulin2024,
  author = {Hulin, Maud and Audigé, Victor and Baghli, Adnan and Larré, Stéphane and Eschwege, Pascal and Bensalah, Karim and Khene, Zine-Eddine},
  title = {Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02578-0}
}
Kostenlos starten →